These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 39077371)

  • 1. Quantitative and qualitative evaluation of liver metastases with intraprocedural cone beam CT prior to transarterial radioembolization as a predictor of treatment response.
    Messmer F; Zgraggen J; Kobe A; Chaykovska L; Puippe G; Reiner CS; Pfammatter T
    Res Diagn Interv Imaging; 2022 Mar; 1():100005. PubMed ID: 39077371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of treatment response to transarterial radioembolization of liver metastases: Radiomics analysis of pre-treatment cone-beam CT: A proof of concept study.
    Kobe A; Zgraggen J; Messmer F; Puippe G; Sartoretti T; Alkadhi H; Pfammatter T; Mannil M
    Eur J Radiol Open; 2021; 8():100375. PubMed ID: 34485629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Therapy Response to Transarterial Radioembolization for Liver Metastases by Means of Post-treatment MRI-Based Texture Analysis.
    Reimer RP; Reimer P; Mahnken AH
    Cardiovasc Intervent Radiol; 2018 Oct; 41(10):1545-1556. PubMed ID: 29881933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy and reproducibility of a cone beam CT-based virtual parenchymal perfusion algorithm in the prediction of SPECT/CT anatomical and volumetric results during the planification of radioembolization for HCC.
    Derbel H; Krichen M; Chalaye J; Saccenti L; Van der Sterren W; Muris AH; Lerman L; Galletto A; Zaarour Y; Luciani A; Kobeiter H; Tacher V
    Eur Radiol; 2023 May; 33(5):3510-3520. PubMed ID: 36651956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computed tomographic perfusion imaging for the prediction of response and survival to transarterial radioembolization of liver metastases.
    Morsbach F; Pfammatter T; Reiner CS; Fischer MA; Sah BR; Winklhofer S; Klotz E; Frauenfelder T; Knuth A; Seifert B; Schaefer N; Alkadhi H
    Invest Radiol; 2013 Nov; 48(11):787-94. PubMed ID: 23748229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative volumetric functional MR imaging: an imaging biomarker of early treatment response in hypo-vascular liver metastasis patients after yttrium-90 transarterial radioembolization.
    Zhu X; Sobhani F; Xu C; Pan L; Ghasebeh MA; Kamel IR
    Abdom Radiol (NY); 2016 Aug; 41(8):1495-504. PubMed ID: 26960726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Liver Metastases During Catheter-Directed Liver Interventions: A Comparison between Dual Phase Cone-Beam Computed Tomography and Conventional Contrast-Enhanced Computed Tomography.
    Maleux G; Izamis ML; Werbrouck C; Radaelli A; Prenen H; Van Cutsem E; Vandecaveye V
    J Belg Soc Radiol; 2020 Jul; 104(1):41. PubMed ID: 32704616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assessment of lipiodol deposition after chemoembolization: comparison between cone-beam CT and multidetector CT.
    Chen R; Geschwind JF; Wang Z; Tacher V; Lin M
    J Vasc Interv Radiol; 2013 Dec; 24(12):1837-44. PubMed ID: 24094672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipiodol retention pattern assessed by cone beam computed tomography during conventional transarterial chemoembolization of hepatocellular carcinoma: accuracy and correlation with response.
    Hu J; Maybody M; Cao G; Wang X; Chen H; Zhu X; Yang R; Wang X
    Cancer Imaging; 2016 Oct; 16(1):32. PubMed ID: 27716376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of early ¹⁸F-FDG PET/CT in prediction of progression-free survival after ⁹⁰Y radioembolization: comparison with RECIST and tumour density criteria.
    Zerizer I; Al-Nahhas A; Towey D; Tait P; Ariff B; Wasan H; Hatice G; Habib N; Barwick T
    Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1391-9. PubMed ID: 22644713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraprocedural C-arm dual-phase cone-beam CT: can it be used to predict short-term response to TACE with drug-eluting beads in patients with hepatocellular carcinoma?
    Loffroy R; Lin M; Yenokyan G; Rao PP; Bhagat N; Noordhoek N; Radaelli A; Blijd J; Liapi E; Geschwind JF
    Radiology; 2013 Feb; 266(2):636-48. PubMed ID: 23143027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent diffusion coefficients (ADC) in response assessment of transarterial radioembolization (TARE) for liver metastases of neuroendocrine tumors (NET): a feasibility study.
    Katharina Ingenerf M; Karim H; Fink N; Ilhan H; Ricke J; Treitl KM; Schmid-Tannwald C
    Acta Radiol; 2022 Jul; 63(7):877-888. PubMed ID: 34225464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of Latest-generation Cone-beam Computed Tomography for Post Lipiodol-embolization Imaging in Hepatic Transarterial Chemoembolization in Comparison with Multi-detector Computed Tomography.
    Alizadeh LS; Koch V; Vogl TJ; Yel I; Gruenewald L; Albrecht MH; Herrmann E; von Knebel-Doeberitz PL; Booz C
    Acad Radiol; 2022 Jul; 29(7):e109-e118. PubMed ID: 34598867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-Enhanced Cone-Beam Breast CT: An Analysis of Diagnostic Value in Predicting Breast Lesion With Rim Enhancement Malignancy.
    Zhao X; Yang J; Zuo Y; Kang W; Liao H; Zheng ZT; Su DK
    Front Oncol; 2022; 12():868975. PubMed ID: 35686106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of Yttrium-90 Radioembolization Dose Calculation Utilizing Intra-procedural Open Trajectory Cone Beam CT.
    O'Connor PJ; Pasik SD; van der Bom IM; Bishay V; Radaelli A; Kim E
    Cardiovasc Intervent Radiol; 2020 Feb; 43(2):295-301. PubMed ID: 31578635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Efficacy of Cone-Beam CT-Based Liver Perfusion Mapping to Predict Initial Response of Hepatocellular Carcinoma to Transarterial Chemoembolization.
    Kim KA; Choi SY; Kim MU; Baek SY; Park SH; Yoo K; Kim TH; Kim HY
    J Vasc Interv Radiol; 2019 Mar; 30(3):358-369. PubMed ID: 30819478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
    Wang Z; Chen R; Duran R; Zhao Y; Yenokyan G; Chapiro J; Schernthaner R; Radaelli A; Lin M; Geschwind JF
    Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1548-56. PubMed ID: 26001366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics-Based Prediction Model for Outcome of Radioembolization in Metastatic Colorectal Cancer.
    Roll W; Masthoff M; Köhler M; Rahbar K; Stegger L; Ventura D; Morgül H; Trebicka J; Schäfers M; Heindel W; Wildgruber M; Schindler P
    Cardiovasc Intervent Radiol; 2024 Apr; 47(4):462-471. PubMed ID: 38416178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential dual-phase cone-beam CT is able to intra-procedurally predict the one-month treatment outcome of multi-focal HCC, in course of degradable starch microsphere TACE.
    Lucatelli P; De Rubeis G; Basilico F; Ginanni Corradini L; Corona M; Bezzi M; Catalano C
    Radiol Med; 2019 Dec; 124(12):1212-1219. PubMed ID: 31473930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early treatment response evaluation after yttrium-90 radioembolization of liver malignancy with CT perfusion.
    Reiner CS; Morsbach F; Sah BR; Puippe G; Schaefer N; Pfammatter T; Alkadhi H
    J Vasc Interv Radiol; 2014 May; 25(5):747-59. PubMed ID: 24630751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.